Pagnesi, M.; Baldetti, L.; Aimo, A.; Inciardi, R.M.; Tomasoni, D.; Vizzardi, E.; Vergaro, G.; Emdin, M.; Lombardi, C.M.
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis. J. Clin. Med. 2022, 11, 348.
https://doi.org/10.3390/jcm11020348
AMA Style
Pagnesi M, Baldetti L, Aimo A, Inciardi RM, Tomasoni D, Vizzardi E, Vergaro G, Emdin M, Lombardi CM.
Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis. Journal of Clinical Medicine. 2022; 11(2):348.
https://doi.org/10.3390/jcm11020348
Chicago/Turabian Style
Pagnesi, Matteo, Luca Baldetti, Alberto Aimo, Riccardo Maria Inciardi, Daniela Tomasoni, Enrico Vizzardi, Giuseppe Vergaro, Michele Emdin, and Carlo Mario Lombardi.
2022. "Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis" Journal of Clinical Medicine 11, no. 2: 348.
https://doi.org/10.3390/jcm11020348
APA Style
Pagnesi, M., Baldetti, L., Aimo, A., Inciardi, R. M., Tomasoni, D., Vizzardi, E., Vergaro, G., Emdin, M., & Lombardi, C. M.
(2022). Prognostic Benefit of New Drugs for HFrEF: A Systematic Review and Network Meta-Analysis. Journal of Clinical Medicine, 11(2), 348.
https://doi.org/10.3390/jcm11020348